Have since 2009 advised (informal or as board member), consulted with, worked at/co-founded several tech startups (e.g Atbrox and Memkite), and for few occasions I’ve done (mostly technical/competitor) due diligence of startups for venture capitalists and potential acquirers evaluating startups.
Regarding working in startup myself I’ve experience with most aspects in early-stage startup (e.g. product development and trying to find product-market-fit, technology choices related to big data and AI, leadership, recruitment, marketing/growth hacking, sales and international contract negotiation, raising private and public funding, and presenting startup for potential acquirers), not all with great success, but have learned a lot.
Some (great) startups I am fortunate to be a (usually small) investor in, most of them through Atbrox (which I co-founded/co-own).
Here is the list of startups:
2.1 Educational Technology
- Declara Inc – Declara provides an AI-powered collaborative network – large customers include California Department of Education, Mexico Teacher’s Union and Education Services Australia (Scootle) – Declara has raised $25M from several investors including GSV Capital (NASDAQ:GSVC), Susa Ventures, Catamount Ventures, DCVC and Founders Fund (Peter Thiel). See also https://en.wikipedia.org/wiki/Declara
- Fixxli AS – Fixxli develops and owns a customizable ed.tech learning platform called Goruu – example customer: the Norwegian Business School
- Vetu AS – Vetu creates digital learning experiences, and helps companies develop learning content for educational technology
2.2 Sharing Economy
- ShareActor.io – ShareActor provides a SaaS solution for providers of sharing economy services. Example customers include: WeClean, Sonans Group and Payr – To learn about Sharing Economy I recommend having a look at Financial Times article: World’s ‘gig economy’ larger than thought
2.3 Medical Informatics
- Vivit AS – Vivit provides services for patient record vendors to detect (using NLP) risk of bad combinations of medicine (e.g. double set of blood thinners can potentially kill a patient)
(Atbrox is the primary owner of Vivit)